Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | TPB | Common Stock | 6.02K | Feb 3, 2022 | Direct | F10 | |||||
holding | TPB | Common Stock | 407 | Feb 3, 2022 | By Spouse | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TPB | Dividend Equivalent Right | Award | $0 | +107 | $0.00 | 107 | Feb 3, 2022 | Common Stock | 107 | Direct | F11, F12 | ||
transaction | TPB | Dividend Equivalent Right | Disposed to Issuer | -107 | -100% | 0 | Apr 29, 2022 | Common Stock | 107 | Direct | F11, F13 | |||
holding | TPB | Options (2022) | 8K | Feb 3, 2022 | Common Stock | 8K | $30.46 | Direct | F8, F9 | |||||
holding | TPB | Options (2021) | 7K | Feb 3, 2022 | Common Stock | 7K | $51.75 | Direct | F2, F3 | |||||
holding | TPB | Options (2020) | 6K | Feb 3, 2022 | Common Stock | 6K | $14.85 | Direct | F2, F4 | |||||
holding | TPB | Options (2019) | 4.8K | Feb 3, 2022 | Common Stock | 4.8K | $47.58 | Direct | F2, F5 | |||||
holding | TPB | Options (2018) | 4.5K | Feb 3, 2022 | Common Stock | 4.5K | $21.21 | Direct | F2, F6 | |||||
holding | TPB | Options (2017) | 3.25K | Feb 3, 2022 | Common Stock | 3.25K | $15.41 | Direct | F2, F7 | |||||
holding | TPB | Options (2017) | 20K | Feb 3, 2022 | Common Stock | 20K | $13.00 | Direct | F2, F7 |
Id | Content |
---|---|
F1 | The reporting person disclaims beneficial ownership of these securities, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purpose. |
F2 | Granted pursuant to the issuer's 2015 Equity Incentive Plan |
F3 | The options vest and become exercisable as to 34% of the underlying shares on January 1, 2022, 33% of the underlying shares on January 1, 2023 and 33% of the underlying shares on January 1, 2024. |
F4 | The options vest and become exercisable as to 34% of the underlying shares on January 1, 2021, 33% of the underlying shares on January 1, 2022 and 33% of the underlying shares on January 1, 2023. |
F5 | The options vest and become exercisable as to 34% of the underlying shares on January 1, 2020, 33% of the underlying shares on January 1, 2021 and 33% of the underlying shares on January 1, 2022. |
F6 | The options vest and become exercisable as to 34% of the underlying shares on January 1, 2019, 33% of the underlying shares on January 1, 2020 and 33% of the underlying shares on January 1, 2021. |
F7 | The options vest and become exercisable as to 34% of the underlying shares on January 1, 2018, 33% of the underlying shares on January 1, 2019 and 33% of the underlying shares on January 1, 2020. |
F8 | The options vest and become exercisable as to 34% of the underlying shares on January 1, 2023, 33% of the underlying shares on January 1, 2024 and 33% of the underlying shares on January 1, 2025. |
F9 | Granted pursuant to the issuer's 2021 Equity Incentive Plan. |
F10 | The total reported in Column 5 includes 2,500 awarded restricted stock units and 3,515 shares of common stock. |
F11 | Each dividend equivalent right was the economic equivalent of one share of the Company's common stock. |
F12 | In connection with the vesting and settlement of previously-granted performance-based restricted stock units, which settled in shares of the Company's common stock on February 3, 2022, the reporting person acquired 107 fully-vested dividend equivalent rights pursuant to the terms of the applicable award agreement. |
F13 | On April 29, 2022, the dividend equivalent rights were disposed of and cancelled in exchange for a cash payment equal to $3,610.42 |